Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma

BACKGROUND: Pyrimidine metabolism is critical for tumour progression. Uridine–cytidine kinase 2 (UCK2), a key regulator of pyrimidine metabolism, is elevated during hepatocellular carcinoma (HCC) development and exhibits carcinogenic effects. However, the key mechanism of UCK2 promoting HCC and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dehai, Zhang, Congyi, Liao, Guanqun, Leng, Kaiming, Dong, Bowen, Yu, Yang, Tai, Huilin, Huang, Lining, Luo, Feng, Zhang, Bin, Zhan, Tiexiang, Hu, Qiuhui, Tai, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707060/
https://www.ncbi.nlm.nih.gov/pubmed/36447138
http://dx.doi.org/10.1186/s11658-022-00403-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707060/
https://www.ncbi.nlm.nih.gov/pubmed/36447138
http://dx.doi.org/10.1186/s11658-022-00403-y

Ejemplares similares